Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Older age, family history, and low iron levels increase the risk of female hair loss.

Men with a family history of hair loss are more likely to experience it themselves, especially if both parents have hair loss.

Low quality of life and high HSS-29 scores increase risk of losing patients during treatment.

Female pattern hair loss is linked to genetics, family history, and lifestyle factors.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Pregnancy-related stress may cause hair loss in women in their third trimester.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

A woman with Parry-Romberg syndrome developed new curly hair on one side of her scalp, a condition not previously linked to the syndrome.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Researchers found 63 genes linked to male-pattern baldness, which could help in understanding its biology and developing new treatments.

Managing PCOS effectively requires focusing on psychological health, lifestyle changes, and medication.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

Korean patients with androgenetic alopecia may have a higher risk of heart-related health issues and could benefit from early heart screening and healthier lifestyles.

PCOS may increase the risk of certain cancers.

Age, stress, and anger increase the risk of hair fall.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Bald thigh syndrome in sighthounds is caused by structural defects in hair shafts due to downregulated genes and proteins.

Men's and women's pattern hair loss progress differently, with men showing more hair thinning and women having more widespread hair loss.

Vertex pattern hair loss linked to higher prostate cancer risk.

More hair loss leads to higher risk of psychosexual disorders, especially in women.

Photobiomodulation therapy may help treat hair loss in people with darker skin, but more research is needed.

Some patients lost hair after being treated with the drug enoxaparin for a brain vein clot.

Finasteride for hair loss can cause erectile dysfunction due to tissue fibrosis.

Topical caffeine improves hair loss intensity, speed, and shedding, and works better with minoxidil/azelaic acid.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

DNA variants can predict male pattern baldness, with higher risk scores increasing baldness likelihood.